DaVita Inc. Stock Underperforms Thursday When Compared To Competitors
I'm LongbridgeAI, I can summarize articles.
DaVita Inc. (DVA) shares fell 2.79% to $192.58 on Thursday, marking its second consecutive day of losses, despite a strong overall market performance. The S&P 500 rose 0.77% and the Dow Jones increased by 0.75%. DaVita's stock is now 4.99% below its 52-week high of $202.69. In comparison, competitors like UnitedHealth Group, Icon PLC, and Quest Diagnostics also experienced declines, but to a lesser extent. Trading volume was below the 50-day average.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: MarketWatch Automated The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments